Prophylactic treatment of retinal breaks reduces RD risk

Article

Prophylactic treatment of retinal breaks during vitrectomy appears to reduce the risk of postoperative retinal detachment (RD).

Prophylactic treatment of retinal breaks during vitrectomy appears to reduce the risk of postoperative retinal detachment (RD), states a paper in Retina.

The retrospective non-comparative interventional case series, led by Dr H.S. Tan, Department of Ophthalmology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands, reviewed the medical records of 89 consecutive cases of 89 patients over a period of four years. The main outcome measures included incidence of breaks, visual acuity outcome and occurrence of postoperative complications.

The findings demonstrated that the visual acuity at the last follow-up visit was ≥0.5 in 70% of patients. Retinal breaks were found in 29% of patients, but induction of a posterior vitreous detachment, the use of a fragmatome or delay between cataract surgery and vitrectomy did not affect retinal break incidence.

Only 2% of cases presented with postoperative RD, one case had intraoperative choroidal haemorrhage, two cases had postoperative macular pucker, one had postoperative macular oedema and glaucoma was recorded in two cases.

A high number of retinal breaks were observed during vitrectomy for retained lens fragments. Prophylactic treatment of retinal breaks appears to reduce the risk of postoperative RD.

Please click here to read the abstract.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.